Holen Sie sich die Stockscreener-App
3.10
5.44%
0.16
Finanzdaten der Tango Therapeutics Inc-Aktie (TNGX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
19.15%
6.471
|
5.431 | 10.73 | 14.60 | 5.766 |
Operating Expenses
|
20.48%
48.73
|
40.44 | 36.36 | 37.84 | 36.05 |
| Benefits Costs and Expenses |
22.68%
44.34
|
36.15 | 32.97 | 35.24 | - |
| Costs And Expenses |
22.68%
44.34
|
36.15 | 32.97 | 35.24 | 36.05 |
| Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
| Operating Income/Loss |
20.68%
-42.26
|
-35.01 | -25.63 | -23.25 | -30.29 |
| Net Interest Income/Expense |
1.74%
2.197
|
2.236 | 1.872 | 1.45 | 1.061 |
| Nonoperating Income/Loss |
1.95%
4.381
|
4.297 | 3.386 | 2.601 | 2.278 |
| Income/Loss From Continuing Operations Before Tax |
23.30%
-37.87
|
-30.72 | -22.24 | -20.65 | -28.01 |
| Income Tax Expense/Benefit |
14.89%
0.04
|
0.047 | 0.023 | 0.064 | - |
| Income/Loss From Continuing Operations After Tax |
23.25%
-37.91
|
-30.76 | -22.26 | -20.71 | -28.01 |
|
Net Income/Loss
|
23.25%
-37.91
|
-30.76 | -22.26 | -20.71 | -28.01 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
3,174%
108.17
|
3.3043 | 97.03 | 88.35 | 88.19 |
| Diluted Average Shares |
3,174%
108.17
|
3.3043 | 97.03 | 88.35 | 88.19 |
| Basic Earnings Per Share |
16.67%
-0.35
|
-0.30 | -0.23 | -0.23 | -0.32 |
| Diluted Earnings Per Share |
16.67%
-0.35
|
-0.30 | -0.23 | -0.23 | -0.32 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):